DarioHealth (NASDAQ:DRIO) Stock Price Passes Below Two Hundred Day Moving Average of $1.53

DarioHealth Corp. (NASDAQ:DRIOGet Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.53 and traded as low as $0.81. DarioHealth shares last traded at $0.83, with a volume of 333,260 shares traded.

DarioHealth Stock Down 5.3 %

The company has a 50-day simple moving average of $1.18 and a 200-day simple moving average of $1.52. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.95 and a quick ratio of 2.67. The firm has a market cap of $23.65 million, a PE ratio of -0.47 and a beta of 1.53.

DarioHealth (NASDAQ:DRIOGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.43. The business had revenue of $6.26 million during the quarter, compared to the consensus estimate of $7.57 million. DarioHealth had a negative return on equity of 76.11% and a negative net margin of 282.38%. Analysts expect that DarioHealth Corp. will post -1.53 earnings per share for the current fiscal year.

Institutional Trading of DarioHealth

An institutional investor recently bought a new position in DarioHealth stock. Clarity Capital Partners LLC purchased a new stake in DarioHealth Corp. (NASDAQ:DRIOFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 170,426 shares of the company’s stock, valued at approximately $293,000. Clarity Capital Partners LLC owned approximately 0.63% of DarioHealth as of its most recent filing with the SEC. 33.39% of the stock is currently owned by institutional investors and hedge funds.

About DarioHealth

(Get Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Further Reading

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.